Janus Henderson Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-683,616
| Closed | -$13.7M | – | 2428 |
|
|
2025
Q1 | $13.7M | Sell |
683,616
-402,032
| -37% | -$8.06M | 0.01% | 641 |
|
|
2024
Q4 | $23.6M | Buy |
1,085,648
+136,314
| +14% | +$2.96M | 0.01% | 541 |
|
|
2024
Q3 | $25.9M | Buy |
949,334
+273,670
| +41% | +$7.48M | 0.01% | 522 |
|
|
2024
Q2 | $17.6M | Buy |
675,664
+300,620
| +80% | +$7.81M | 0.01% | 591 |
|
|
2024
Q1 | $11.3M | Buy |
+375,044
| New | +$11.3M | 0.01% | 671 |
|
|
2022
Q4 | – | Sell |
-413,612
| Closed | -$9.5M | – | 2467 |
|
|
2022
Q3 | $9.5M | Buy |
413,612
+225,876
| +120% | +$5.19M | ﹤0.01% | 836 |
|
|
2022
Q2 | $3.57M | Buy |
187,736
+68,066
| +57% | +$1.3M | ﹤0.01% | 916 |
|
|
2022
Q1 | $5.53M | Buy |
119,670
+110,173
| +1,160% | +$5.09M | ﹤0.01% | 994 |
|
|
2021
Q4 | $672K | Sell |
9,497
-27,778
| -75% | -$1.97M | ﹤0.01% | 1711 |
|
|
2021
Q3 | $4.34M | Buy |
37,275
+30,109
| +420% | +$3.5M | ﹤0.01% | 1088 |
|
|
2021
Q2 | $1.12M | Sell |
7,166
-6,741
| -48% | -$1.06M | ﹤0.01% | 1311 |
|
|
2021
Q1 | $2.63M | Buy |
+13,907
| New | +$2.63M | ﹤0.01% | 1137 |
|